- Off Label
- Posts
- 🌱 Teen Use Hits Low, MediPharm's $5.5M Deal, Industry CEO Tips
🌱 Teen Use Hits Low, MediPharm's $5.5M Deal, Industry CEO Tips
Welcome to Rise & Roll, a bi-weekly newsletter that keeps you smart, savvy, and always in the loop on the latest in cannabis.
Here’s what we have on deck for today…
Teen cannabis use hits 30-year low
When state legalization first became a thing, people were concerned that cannabis use would skyrocket among younger generations.
Funny enough, new federal data reveals a significant decline in teen cannabis use since states have begun legalizing.
The University of Michigan's Monitoring the Future survey shows usage drops of 30-40% across all student age groups over the past decade, reaching a 30-year low.
This survey provides proof that legal markets can operate successfully without increasing youth consumption, offering valuable support for business development and policy discussions, particularly when addressing public health concerns about legalization's impact on adolescents.
MediPharm's $5.5M facility sale signals focus on global cannabis market
MediPharm Labs is making moves in the cannabis space — they just sold their Ontario facility to Kensana Health for $5.5 million.
But here's the interesting part — this isn't just a simple sale:
The companies are forming a strategic partnership where Kensana will supply products for MediPharm's international brands
For MediPharm, this deal does double duty:
Streamlining operations
Strengthening their cash position for future growth
This sale gives Kensana the keys to expand into global markets, with plans to pursue FDA registration and approvals across Europe, the UK, and beyond.
Lessons from cannabis industry CEOs
Leading cannabis executives — Christina Betancourt Johnson (Founder and CEO of Standard Wellness Maryland, Will Bowden (Founder and CEO of Grasshopper Farms), Jason Vedadi, (CEO of Story Cannabis), Gibran Washington (CEO of Ethos Cannabis) recently shared their top lessons learned with Cannabis Business Times.
Here are three fundamental principles for success, supported by each executive:
Establish a strong foundation in a single market before expansion
Develop business models that don't rely on federal reform
Prioritize employee well-being to drive company performance
If you enjoyed this edition of Rise & Roll, please share it with your friends!
We’ll be back with another edition on Friday. See you then!
To stay up-to-date on cannabis news, visit us at riseandroll.news.
What did you think of today's edition |